Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 3 |
iShares Silver Trust
SLV
|
+$1.03B |
| 4 |
Walmart Inc
WMT
|
+$862M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$850M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.99B |
| 2 |
Micron Technology
MU
|
+$1.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$772M |
| 4 |
Tesla
TSLA
|
+$700M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$639M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.77% |
| 2 | Healthcare | 1.08% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.94% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEV
10526
PUT
Aptera Motors
SEV
$88.4M
| $43.3K | ﹤0.01% |
+10,100
| New | +$63.2K |
|
10527
Cyngn
CYN
$16M
| $43.2K | ﹤0.01% |
+18,145
| New | +$75K |
|
|
RC
10528
PUT
Ready Capital
RC
$306M
| $43.2K | ﹤0.01% |
+19,800
| New | +$55.5K |
|
10529
CALL
Arq
ARQ
$102M
| $43.2K | ﹤0.01% |
13,200
-21,100
| -62% | -$103K |
|
10530
PUT
Pulmonx
LUNG
$104M
| $43.1K | ﹤0.01% |
+19,500
| New | +$36.7K |
|
|
HITI
10531
CALL
High Tide
HITI
$206M
| $42.8K | ﹤0.01% |
+16,000
| New | +$47.5K |
|
|
SAFX
10532
XCF Global Inc
SAFX
$178M
| $42.3K | ﹤0.01% |
+155,068
| New | +$121K |
|
10533
Oxford Square Capital
OXSQ
$157M
| $42K | ﹤0.01% |
23,865
-273,906
| -92% | -$498K |
|
|
BRAG
10534
Bragg Gaming Group
BRAG
$47.2M
| $42K | ﹤0.01% |
20,009
+6,072
| +44% | +$14.4K |
|
|
YARW
10535
Yarrow Bioscience
YARW
$113M
| $42K | ﹤0.01% |
1,447
-1,495
| -51% | -$30K |
|
10536
Evogene
EVGN
$9.49M
| $41.7K | ﹤0.01% |
37,942
-1,481
| -4% | -$1.73K |
|
|
CAN
10537
PUT
Canaan Creative
CAN
$171M
| $41.7K | ﹤0.01% |
60,400
+45,800
| +314% | +$52.5K |
|
|
FURY
10538
Fury Gold Mines
FURY
$117M
| $41.4K | ﹤0.01% |
+70,183
| New | +$43.2K |
|
|
CRDL
10539
CALL
Cardiol Therapeutics
CRDL
$207M
| $41.1K | ﹤0.01% |
+43,000
| New | +$45K |
|
10540
CALL
Companhia Siderúrgica Nacional
SID
$1.17B
| $40.8K | ﹤0.01% |
+25,500
| New | +$41.4K |
|
|
NCNA
10541
NuCana
NCNA
$6.62M
| $40.8K | ﹤0.01% |
11,330
-1,433
| -11% | -$5.93K |
|
|
BHR
10542
PUT
Braemar Hotels & Resorts
BHR
$139M
| $40.8K | ﹤0.01% |
+14,200
| New | +$38.3K |
|
|
CODX
10543
Co-Diagnostics
CODX
$9.77M
| $40.6K | ﹤0.01% |
8,031
+5,956
| +287% | +$64.8K |
|
10544
CALL
Actinium Pharmaceuticals
ATNM
$32.6M
| $40.4K | ﹤0.01% |
+29,700
| New | +$43.3K |
|
|
ZOOZ
10545
ZOOZ Strategy Ltd
ZOOZ
$43.3M
| $40.2K | ﹤0.01% |
4,591
+3,566
| +348% | +$71.8K |
|
|
TONX
10546
PUT
TON Strategy Co
TONX
$148M
| $40K | ﹤0.01% |
20,100
-16,200
| -45% | -$59.2K |
|
10547
Senti Biosciences Holdings
SNTI
$14M
| $40K | ﹤0.01% |
+38,427
| New | +$67.9K |
|
10548
Aprea Therapeutics
APRE
$8.42M
| $39.8K | ﹤0.01% |
+46,621
| New | +$57.2K |
|
10549
ReWalk Robotics
LFWD
$21M
| $39.6K | ﹤0.01% |
5,719
+2,494
| +77% | +$19.4K |
|
10550
Avita Medical
RCEL
$243M
| $39.2K | ﹤0.01% |
11,366
-59,061
| -84% | -$236K |
|
Similar funds
Jane Street's Q4 2025 Portfolio in Review
As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
- Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
- Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
- Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
- Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
- Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.